Ibuprofen: how an everyday drug might offer protection against cancer
By Dipa Kamdar, Senior Lecturer in Pharmacy Practice, Kingston University
Ahmed Elbediwy, Senior Lecturer in Cancer Biology & Clinical Biochemistry, Kingston University
Nadine Wehida, Senior Lecturer in Genetics and Molecular Biology, Kingston University
Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests this everyday drug might be doing more than easing discomfort. It could also have anti-cancer properties.
As scientists uncover more about the links between inflammation and cancer, ibuprofen’s role is coming under the spotlight – raising intriguing questions about how something so familiar might offer unexpected protection.
Ibuprofen belongs to the non-steroidal anti-inflammatory drugs (NSAIDs) family. The connection between NSAIDs and
Read complete article
© The Conversation
-
Thursday, October 16, 2025